Search for: "Biogen Idec, Inc." Results 101 - 113 of 113
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Dec 2008, 8:00 pm
In a nonprecedential opinion today, Classen Immunotherapies, Inc. v. [read post]
9 Dec 2008, 11:51 pm
She also has corporate experience in the life sciences sector, as both senior vice president and general counsel at ViaCell, Inc. and vice president and chief corporate counsel at Biogen Idec. [read post]
23 Oct 2008, 10:31 am
" Meanwhile, "Rituxan (rituximab), which Genentech sells with Biogen-Idec Inc. for lymphoma, caused rare cases of...progressive multifocal leukoencephalopathy (PML)," a condition that "is also tied to Biogen's multiple sclerosis drug Tysabri (natalizumab). [read post]
7 Aug 2008, 8:16 pm
Biogen Idec Inc., No. 07-2626 affirms the dismissal of a Private Securities Litigation Reform Act of 1995 ("PSLRA"), Pub. [read post]
12 Jun 2008, 11:32 am
Icahn’s slate of nominees to Biogen Idec’s board, reducing his odds of success. [read post]
8 Feb 2008, 7:00 pm
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
1 Feb 2008, 1:24 am
According to the IP Kat reporting on Glaxo Group Ltd v Genentech Inc and Biogen Idec Inc. [2008] EWCA Civ 23, the UK Court of Appeal confirmed the Patent Court's decision to permit a British national invalidity proceeding to go forward without suspension, despite the existence of a parallel opposition proceeding at the EPO. [read post]
29 Jan 2008, 4:26 am
Icahn renewed his efforts Monday to push Biogen Idec Inc. to find a buyer, saying last year’s failed effort to sell the Cambridge, [...] [read post]
4 May 2007, 2:56 pm
Biogen Idec Inc. and Elan Corp., also said there were no reports of other "serious opportunistic infections," as of April 23. [read post]
17 Apr 2007, 1:18 am
According to the settlement, the case has been dismissed.Genzyme and Biogen Idec Inc. settled another IP lawsuit in August 2005 with Columbia University, over patents that had raised over $600 million in royalties for the university. [read post]